Viewing Study NCT00171951


Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-02-24 @ 5:08 AM
Study NCT ID: NCT00171951
Status: COMPLETED
Last Update Posted: 2021-06-02
First Post: 2005-09-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cushing Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cushing's disease View
None ACTH View
None Cortisol View
None ACTH dependent Cushing's disease View